Zimmer Biomet Holdings, Inc. (ZBH)
$89.14+0.29%Close
SELLBEAR · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $17.2B
- Beta
- 0.47
- Div yield
- 1.07%
- P/E (TTM)
- 21.71
- Short % float
- 5.05%
- Days to cover
- 4.4
- SI change
- +13.6%
- 1W
- +0.96%
- 1M
- -3.31%
- vs SPY 1W
- -0.20%
- vs SPY 1M
- -6.30%
Industry peers
FMP comparable companies · ranked by market cap
- MDTSELLMedtronic Plc$113.3BBEARQ 14$88.48+0.83%
- SYKSELLStryker Corporation$106.3BRECOVERYQ 25$277.33+0.13%
- BSXSELLBoston Scientific Corporation$63.5BRECOVERYQ 6$42.73+1.64%
- EWSELLEdwards Lifesciences Corporation$49.1BBEARQ 18$85.21+1.15%
- GEHCSELLGE HealthCare Technologies Inc.$29.7BRECOVERYQ 6$65.74+2.37%
- PHGSELLKoninklijke Philips N.V.$23.7BBEARQ 10$24.24-0.25%
- TRUMYTerumo Corporation$21.1B$14.28
- SNNSELLSmith & Nephew plc$11.4BRECOVERYQ 15$27.24+1.04%
- ALGNSELLAlign Technology, Inc.$10.2BRECOVERYQ 15$142.71+1.19%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ZBH?
- LOPJLB’s latest quantitative signal on Zimmer Biomet Holdings, Inc. (ZBH) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is ZBH in?
- Zimmer Biomet Holdings, Inc. (ZBH) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Zimmer Biomet Holdings, Inc. (ZBH) do?
- Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Eur…